Since downstream signaling pathways through TLRs involve Myd88 as an adaptor molecule, we provided MYD88 expression patterns in peripheral blood and bone marrow, referring to CLL prognostic factors as well as an association between MYD88 and TLRs expression in both compartments. Here, MYD88 is linked to B-cell chronic lymphocytic leukemia.